• Tidak ada hasil yang ditemukan

COPD: Chronic Obstructive Pulmonary Disease

N/A
N/A
Protected

Academic year: 2025

Membagikan "COPD: Chronic Obstructive Pulmonary Disease"

Copied!
22
0
0

Teks penuh

(1)

Advanced COPD Training Course

“COPD & Asthma Are Not the Same”

COPD: Chronic Obstructive

Pulmonary Disease

(2)

Advanced COPD Training Course

“COPD & Asthma Are Not the Same”

The Global Initiative for

Chronic Obstructive Lung Disease (GOLD) Guidelines 2007

National Heart, Lung, and Blood Institute World Health Organization

Am J Respir Crit Care Med.2007,176:532-555

New Definition of COPD

• COPD is a preventable and treatable disease with some significant extrapulmonary effects that may contribute to the severity in individual patients.

• Its pulmonary component is characterized by airflow limitation that is not fully reversible.

• The airflow limitation is usually progressive and

associated with an abnormal inflammatory response of

the lung to noxious particles or gases.

(3)

Advanced COPD Training Course

“COPD & Asthma Are Not the Same”

Classification

Classification of COPD Severity by Spirometry

Stage Characteristics

I: Mild COPD - FEV1/FVC <70%

- FEV1≥80% predicted

- With or without chronic symptoms (cough, sputum production) II: Moderate COPD - FEV1/FVC <70%

- 50% ≤FEV1 <80% predicted III: Severe COPD - FEV1/FVC <70%

- 30% ≤FEV1<50% predicted IV: Very severe COPD - FEV1/FVC <70%

- FEV1<30% predicted or FEV1<50% predicted plus respiratory failure or clinical signs of right heart failure

(4)

Advanced COPD Training Course

“COPD & Asthma Are Not the Same”

Epidemiology

• The prevalence of COPD varies but it is directly related to the prevalence of TOBACCO smoking

• The prevalence is projected to increase in the coming decades due to continued exposure to COPD risk factors

• The disease is under-recognized and under- diagnosed

Epidemiology

(5)

Advanced COPD Training Course

“COPD & Asthma Are Not the Same”

Of the six leading causes of death in the United States, only COPD has been increasing

steadily since 1970

Source: Jemal A. et al. JAMA2005

In Saudi Arabia?

(6)

Advanced COPD Training Course

“COPD & Asthma Are Not the Same”

• According to one report released by the executive office of the GCC Health Ministers Council, Saudi Arabia is the world’s fourth largest importer of cigarettes.

• During the year of 2004, the kingdom imported 41,000 tons of tobacco at a value of SR 1.45 billion.

COPD Prevalence in KSA (Contd.)

• The estimated number of COPD patients in KSA is somewhere between:

357 Thousands Patients

214 Thousands Patients

• The number of currently diagnosed COPD patients in KSA doesn’t exceed 45,000 patients

COPD Prevalence in KSA (Contd.)

(7)

Advanced COPD Training Course

“COPD & Asthma Are Not the Same”

• Risk factors

• Burden of COPD

Risk Factors for COPD

Nutrition Nutrition Infections Infections Socio

Socio--economic economic status

status

AGING AGING GENETIC

GENETIC RISK

RISK

FACTOR

FACTOR

(8)

Advanced COPD Training Course

“COPD & Asthma Are Not the Same”

Burden of COPD

(9)

Advanced COPD Training Course

“COPD & Asthma Are Not the Same”

How many lives are lost to COPD?

• In 2000, COPD was the 4

th

leading cause of death in the USA after heart diseases, cancer, and

cerebrovascular diseases.

• Worldwide, 3 million people die from COPD every year.

• According to WHO, COPD kills more people than cancer, and as many people as HIV/AIDS.

www.goldcopd.org

Global Burden of Disease (1990–2020)

Lower respiratory tract infections

1

Diarrhoeal diseases 2 Conditions during perinatal period

3

Unipolar major depression 4 Ischaemic heart disease 5 Cerebrovascular disease 6

Tuberculosis 7

Measles 8

Road traffic accidents 9 Congenital anomalies 10

Malaria 11

COPD 12

1 Ischaemic heart disease 2 Unipolar major depression 3 Road traffic accidents 4 Cerebrovascular disease

5 COPD

6 Lower respiratory tract infections 7 Tuberculosis

8 War

9 Diarrhoeal diseases 10 HIV

11 Conditions during prenatal period 12 Violence

1990 2020

(10)

Advanced COPD Training Course

“COPD & Asthma Are Not the Same”

Projected Global Mortality From COPD

0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.5

1990 2000 2010 2020

Murray CJL, Lopez AD.

Lancet. 1997;349:1498

4.0

M o rt a li ty ( × 10 )

6

Year

Burden of COPD: Key Points

• COPD is a leading cause of morbidity and mortality worldwide and results in an economic and social burden that is both substantial and increasing.

• COPD morbidity, and mortality vary across countries and across different groups within countries.

• The burden of COPD is projected to increase in the

coming decades due to continued exposure to COPD

risk factors and the changing age structure of the

world’s population.

(11)

Advanced COPD Training Course

“COPD & Asthma Are Not the Same”

• Pathology

• Pathogenesis

• Pathophysiology

Small airways

Airway inflammation Airway remodeling

Pathologic Changes in COPD

Lung Parenchyma

Inflammation

Loss of alveolar attachments elastic recoil

AIRWAY LIMITATION

(12)

Advanced COPD Training Course

“COPD & Asthma Are Not the Same”

LUNG INFLAMMATION LUNG INFLAMMATION

COPD PATHOLOGY COPD PATHOLOGY

Oxidative Oxidative

stress

stress Proteinases Proteinases

Host factors Amplifying mechanisms

Source: Peter J. Barnes, MD

Pathogenesis of COPD

Pathophysiological Features of COPD

Normal COPD

(13)

Advanced COPD Training Course

“COPD & Asthma Are Not the Same”

Pathophysiological Features of COPD

Pathophysiological Features of COPD

(14)

Advanced COPD Training Course

“COPD & Asthma Are Not the Same”

Hypoxemia Hypoxemia

Pulmonary Vasoconstriction Pulmonary Vasoconstriction

Pulmonary Arterial Hypertension Pulmonary Arterial Hypertension

Right Heart Failure (Cor Pulmonale) Right Heart Failure (Cor Pulmonale)

Pulmonary Hypertension in COPD

Systemic Effects of COPD

• Increased oxidative stress and altered

circulating levels of inflammatory mediators and acute-phase proteins

• Weight loss

• Muscle wasting

• Tissue depletion

• Reduced exercise capacity

Wouters EF, et al. Chest.2002;121(suppl 5):127S-130S.

(15)

Advanced COPD Training Course

“COPD & Asthma Are Not the Same”

ASTHMA ASTHMA

Sensitizing agent COPD COPD

Noxious agent

Asthmatic airway inflammation CD4+ T-lymphocytes

Eosinophils Mast calls

COPD airway inflammation CD8 + T-lymphocytes

Macrophages Neutrophils

Airflow Limitation

Completely

reversible Incompletely

reversible

How to reach the diagnosis of COPD ?

§ History

§ Physical Examination

§ Spirometry

§ Radiology

§ Others

(16)

Advanced COPD Training Course

“COPD & Asthma Are Not the Same”

SYMPTOMS cough cough sputum sputum dyspnea dyspnea

EXPOSURE TO RISK FACTORS

tobacco tobacco occupation occupation

indoor/outdoor pollution indoor/outdoor pollution

SPIROMETRY SPIROMETRY

Diagnosis of COPD Diagnosis of COPD

èè

§ Chronic cough:

ü Initially in the morning.

ü Often progresses to occur throughout the day.

ü Seldom only nocturnal.

§ Sputum production:

ü Any pattern of sputum production may indicate COPD.

ü The daily volume rarely exceeds 60 ml

Diagnosis : HISTORY

(17)

Advanced COPD Training Course

“COPD & Asthma Are Not the Same”

§ Dyspnea

ü Most patients seek medical attention due to dyspnea

ü Initially may be noticed only with exertion

ü It progressively worsens, persistent,

Diagnosis : HISTORY

§ Wheezing:

ü Indicates airway narrowing

ü More during expiration

§ Early stages of COPD: may have an entirely normal physical examination

Physical Examination

(18)

Advanced COPD Training Course

“COPD & Asthma Are Not the Same”

More Severe Disease

§ Signs of hyperinflation ü Barrel chest,

ü Enlarged lung volumes with poor diaphragmatic excursion

§ Signs of severe airflow obstruction:

ü Use of accessory muscles of respiration

Physical Examination

(19)

Advanced COPD Training Course

“COPD & Asthma Are Not the Same”

Physical Examination

§ Decreased intensity of breath and heart sounds

§ Prolonged expiratory phase

§ Wheezes

§ Central cyanosis (lips and nail beds)

Physical Examination

§ None of these signs are specific to COPD and do not correlate very well with the severity of the disease

§ Their presence should alert the physician to the

possible diagnosis of COPD.

(20)

Advanced COPD Training Course

“COPD & Asthma Are Not the Same”

Physical Examination

Advanced Disease

Signs of Right Heart Failure (Cor Pulmonale )

§ Elevated jugular venous pressures

§ Right ventricular heave or third heart sound

§ Hepatic congestion, ascites, and peripheral edema as the right ventricle decompensated as a result of chronic pulmonary hypertension

Physical Examination

(21)

Advanced COPD Training Course

“COPD & Asthma Are Not the Same”

CLINICAL PATTERNS IN SEVERE COPD

(22)

Advanced COPD Training Course

“COPD & Asthma Are Not the Same”

Wayne McLaren…Former Marlboro Man

Age 30…a robust young man

Age 51…riding into the sunset

• Diagnostic Measures: SPIROMETRY

Referensi

Dokumen terkait

Menurut WHO yang dituangkan dalam Panduan Global Initiative for Chronic Obstructive Lung Disease (GOLD) tahun 2011, Chronic Obstructive Pulmonary Disease (COPD) atau

Hari PPOK Sedunia adalah even tahunan yang diselenggarakan sejak tahun 2002 atas Prakarsa Global Initiative for Chronic Obstructive Lung Disease (GOLD) yang

The intrathoracic pressure was determined by direct intrapleural cannulation in 17 clinically normal horses and 14 horses with chronic obstructive pulmonary disease COPD.. There were

This is because many patients found to have NTMs in their sputum already have chronic lung disease of other causes such as asthma, chronic obstructive pulmonary disease COPD, cystic

Causes  Most cases of COPD occur as a result of long-term exposure to lung irritants that damage the lungs and the airways  The most common irritant that causes COPD is cigarette

In the present study we have compared the prevalence of chronic respiratory symptoms, lung function impairment, and chronic obstructive respiratory diseases between dairy farmers and

Swine Flu Influenza A, H1N1pdm2009 Infection on an Elderly Patient with Chronic Obstructive Pulmonary Disease COPD: A Case Report Anak Agung Bagus Bramardipa1 1Internship Doctor,

The Global Initiative for Chronic Obstructive Lung Disease GOLD guidelines recommend the regular use of a long-acting bronchodilator, either a long-acting β-2 agonist LABA or a